Form D · Biotechnology
NuVera Medical, Inc.
Campbell, CA · CIK 0001711500
Offering snapshot reported Jul 13, 2017 · SEC filing
- Reported sold
- $11.7M Offering amount: $11.7M
- Investors reported
- 14 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Jun 28, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 13, 2017 | Initial | $11,700,000 | No comparison | 14 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-290641
The Total Offering Amount and Total Amount Sold reflect the value of shares of common stock to be acquired upon exercise of the warrant.
Source: Form D, filed Jul 13, 2017. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Casey Gordon | Director |
| Mariam Maghribi | Executive |
| Amr Salahieh | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
745 Camden Avenue, Suite A
Campbell, CA, 95008
Campbell, CA, 95008